VCMCVC Market Cap
Menu

Aidoc valuation, funding and investors

Aidoc works in clinical AI solutions development, based in New York, United States. Founded in 2016, it has about 628 employees.

VALUATION · TODAY
$2.34B +16% after Series E
Range $1.47B – $3.84B · Grade B
TODAY
+12 MO
$1.00B
$2.00B
$3.00B
$4.00B
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Series B $27.0M
Series C $66.0M
Series D $110M
Growth $150M
Series E $150M
ValuationBefore first round12-month outlook: where it points, how wide it fansHover the past: the outlook shows what was predicted then
HEADCOUNT · TODAY621 employees
+22%6m growth
+22%1y growth
+29%2y growth
250
500
750
Data from Jan 2021
TODAY
Predicted in 1 yr $2.71B +16% vs today
Predicted next raise $298M if a round comes
Winding-down probability 0%
Last round
Series E · $150M · Apr 2026
Valuation at last round
$2.03B · implied
Headcount
621 · up
Grade
B
Founded
2016
How VCMC values companies →

Aidoc valuation today

VCMC values Aidoc at $2.3B today, with a range of $1.5B to $3.8B and a grade of B. The valuation starts from its last funding round, a Series E round in Apr 2026.

Valuation by date (136 rows)

Each point is what the model would have shown on that date, using only what was known then; before its first round, a company is valued as a startup because it later raised.

Aidoc: valuation by date, as the model would have shown it on each date
DateValuationRangePredicted in 1 yrPhaseHeadcountTrendGradeWinding-down probability
1 Jan 2016$5.41M$1.97M – $14.9M$6.49M (+20%)before first round–unknownD0%
1 Feb 2016$5.44M$1.98M – $14.9M$6.67M (+23%)before first round–unknownD0%
1 Mar 2016$5.46M$1.99M – $15.0M$6.84M (+25%)before first round–unknownD0%
1 Apr 2016$5.48M$1.99M – $15.0M$7.02M (+28%)before first round–unknownD0%
1 May 2016$5.50M$2.00M – $15.1M$7.21M (+31%)before first round–unknownD0%
1 Jun 2016$5.52M$2.01M – $15.2M$7.40M (+34%)before first round–unknownD0%
1 Jul 2016$5.54M$2.02M – $15.2M$7.60M (+37%)before first round–unknownD0%
1 Aug 2016$5.69M$2.07M – $15.6M$7.80M (+37%)before first round–unknownD0%
1 Sep 2016$5.84M$2.13M – $16.1M$8.01M (+37%)before first round–unknownD0%
1 Oct 2016$6.00M$2.18M – $16.5M$8.22M (+37%)before first round–unknownD0%
1 Nov 2016$6.16M$2.24M – $16.9M$8.45M (+37%)before first round–unknownD0%
1 Dec 2016$6.32M$2.30M – $17.4M$8.67M (+37%)before first round–unknownD0%
1 Jan 2017$6.49M$2.36M – $17.8M$8.90M (+37%)before first round–unknownD0%
1 Feb 2017$6.67M$2.43M – $18.3M$9.14M (+37%)before first round–unknownD0%
1 Mar 2017$6.83M$2.49M – $18.8M$9.36M (+37%)before first round–unknownD0%
1 Apr 2017$7.01M$2.55M – $19.3M$9.62M (+37%)before first round–unknownD0%
1 May 2017$7.20M$2.62M – $19.8M$9.87M (+37%)before first round–unknownD0%
1 Jun 2017$7.39M$2.69M – $20.3M$10.1M (+37%)before first round–unknownD0%
1 Jul 2017$7.59M$2.76M – $20.8M$10.4M (+37%)before first round–unknownD0%
1 Aug 2017$7.79M$2.84M – $21.4M$10.7M (+37%)before first round–unknownD0%
1 Sep 2017$8.01M$2.91M – $22.0M$11.0M (+37%)before first round–unknownD0%
1 Oct 2017$8.22M$2.99M – $22.6M$11.3M (+37%)before first round–unknownD0%
1 Nov 2017$8.44M$3.07M – $23.2M$11.6M (+37%)before first round–unknownD0%
1 Dec 2017$8.66M$3.15M – $23.8M$11.9M (+37%)before first round–unknownD0%
1 Jan 2018$8.90M$3.24M – $24.4M$12.2M (+37%)before first round–unknownD0%
1 Feb 2018$9.14M$3.33M – $25.1M$12.5M (+37%)before first round–unknownD0%
1 Mar 2018$9.36M$3.41M – $25.7M$12.8M (+37%)before first round–unknownD0%
1 Apr 2018$9.62M$3.50M – $26.4M$13.2M (+37%)before first round–unknownD0%
1 May 2018$9.87M$3.59M – $27.1M$13.5M (+37%)before first round–unknownD0%
1 Jun 2018$10.1M$3.69M – $27.8M$13.9M (+37%)before first round–unknownD0%
1 Jul 2018$10.4M$3.79M – $28.6M$14.3M (+37%)before first round–unknownD0%
1 Aug 2018$10.7M$3.89M – $29.4M$14.4M (+35%)before first round–unknownD0%
1 Sep 2018$11.0M$4.00M – $30.2M$14.5M (+32%)before first round–unknownD0%
1 Oct 2018$11.3M$4.10M – $30.9M$14.7M (+30%)before first round–unknownD0%
1 Nov 2018$11.6M$4.21M – $31.8M$14.8M (+28%)before first round–unknownD0%
1 Dec 2018$11.9M$4.32M – $32.6M$14.9M (+26%)before first round–unknownD0%
1 Jan 2019$12.2M$4.44M – $33.5M$15.1M (+24%)before first round–unknownD0%
1 Feb 2019$12.5M$4.56M – $34.4M$15.2M (+21%)before first round–unknownD0%
1 Mar 2019$12.8M$4.67M – $35.3M$15.3M (+19%)before first round–unknownD0%
1 Apr 2019$13.2M$4.80M – $36.2M$15.5M (+17%)before first round–unknownD0%
18 Apr 2019$193M$127M – $440M$289M (+50%)after a round–unknownC0%
1 May 2019$196M$127M – $440M$289M (+48%)after a round–unknownC0%
1 Jun 2019$203M$127M – $440M$289M (+43%)after a round–unknownC0%
1 Jul 2019$210M$127M – $440M$289M (+38%)after a round–unknownC0%
1 Aug 2019$217M$127M – $440M$289M (+33%)after a round–unknownC0%
1 Sep 2019$225M$127M – $440M$289M (+29%)after a round–unknownC0%
1 Oct 2019$232M$127M – $440M$289M (+25%)after a round–unknownC0%
1 Nov 2019$240M$127M – $440M$289M (+20%)after a round–unknownC0%
1 Dec 2019$248M$127M – $440M$289M (+16%)after a round–unknownC0%
1 Jan 2020$257M$127M – $440M$289M (+13%)after a round–unknownC0%
1 Feb 2020$266M$127M – $440M$289M (+9%)after a round–unknownC0%
1 Mar 2020$275M$127M – $440M$289M (+5%)after a round–unknownC0%
1 Apr 2020$284M$127M – $440M$289M (+2%)after a round–unknownC0%
1 May 2020$289M$124M – $440M$289M (0%)after a round–unknownC0%
1 Jun 2020$289M$119M – $440M$289M (0%)after a round–unknownC0%
1 Jul 2020$289M$114M – $440M$289M (0%)after a round–unknownC0%
1 Aug 2020$289M$109M – $440M$289M (0%)after a round–unknownC0%
1 Sep 2020$289M$104M – $440M$289M (0%)after a round–unknownC0%
1 Oct 2020$289M$99.8M – $440M$289M (0%)after a round–unknownC0%
1 Nov 2020$289M$95.4M – $440M$289M (0%)after a round–unknownC0%
1 Dec 2020$289M$91.4M – $440M$289M (0%)after a round–unknownC0%
1 Jan 2021$289M$87.5M – $440M$289M (0%)after a round120unknownC0%
1 Feb 2021$289M$83.7M – $440M$289M (0%)after a round120unknownC0%
1 Mar 2021$289M$80.4M – $440M$289M (0%)after a round120unknownC0%
1 Apr 2021$289M$77.0M – $440M$289M (0%)after a round120flatC0%
1 May 2021$289M$67.9M – $440M$288M (0%)after a round120flatC0%
1 Jun 2021$289M$64.5M – $440M$286M (-1%)after a round120flatC0%
1 Jul 2021$289M$61.4M – $440M$283M (-2%)after a round120flatC0%
14 Jul 2021$547M$385M – $1.0B$711M (+30%)after a round120flatB0%
1 Aug 2021$555M$385M – $1.0B$711M (+28%)after a round120flatB0%
1 Sep 2021$567M$385M – $1.0B$711M (+25%)after a round120flatB0%
1 Oct 2021$579M$385M – $1.0B$711M (+23%)after a round120flatB0%
1 Nov 2021$592M$385M – $1.0B$711M (+20%)after a round120flatB0%
1 Dec 2021$605M$385M – $1.0B$711M (+17%)after a round120flatB0%
1 Jan 2022$619M$385M – $1.0B$711M (+15%)after a round120flatB0%
1 Feb 2022$696M$457M – $1.2B$843M (+21%)after a round260growingB0%
1 Mar 2022$719M$457M – $1.2B$843M (+17%)after a round260growingB0%
1 Apr 2022$746M$457M – $1.2B$843M (+13%)after a round260growingB0%
1 May 2022$773M$457M – $1.2B$843M (+9%)after a round260growingB0%
1 Jun 2022$802M$457M – $1.2B$843M (+5%)after a round260growingB0%
17 Jun 2022$1.2B$818M – $2.1B$1.5B (+30%)after a round260growingB0%
1 Jul 2022$1.2B$818M – $2.1B$1.5B (+29%)after a round260growingB0%
1 Aug 2022$1.2B$818M – $2.1B$1.5B (+26%)after a round260growingB0%
1 Sep 2022$1.2B$818M – $2.1B$1.5B (+23%)after a round260growingB0%
1 Oct 2022$1.3B$818M – $2.1B$1.5B (+20%)after a round260growingB0%
1 Nov 2022$1.3B$818M – $2.1B$1.5B (+18%)after a round260unknownB0%
1 Dec 2022$1.3B$818M – $2.1B$1.5B (+15%)after a round260unknownB0%
1 Jan 2023$1.3B$818M – $2.1B$1.5B (+13%)after a round260unknownB0%
1 Feb 2023$1.4B$818M – $2.1B$1.5B (+10%)after a round260unknownB0%
1 Mar 2023$1.4B$818M – $2.1B$1.5B (+8%)after a round260unknownB0%
1 Apr 2023$1.5B$894M – $2.3B$1.7B (+8%)after a round390growingB0%
1 May 2023$1.6B$894M – $2.3B$1.7B (+5%)after a round390growingB0%
1 Jun 2023$1.6B$894M – $2.3B$1.7B (+1%)after a round390growingB0%
1 Jul 2023$1.7B$897M – $2.3B$1.7B (0%)after a round390growingB0%
1 Aug 2023$1.7B$902M – $2.3B$1.7B (0%)after a round390growingB0%
1 Sep 2023$1.7B$797M – $2.3B$1.7B (0%)after a round390unknownB0%
1 Oct 2023$1.7B$771M – $2.4B$1.7B (0%)after a round410flatB0%
1 Nov 2023$1.7B$736M – $2.4B$1.7B (0%)after a round410flatB0%
1 Dec 2023$1.7B$704M – $2.4B$1.7B (0%)after a round410flatC0%
1 Jan 2024$1.7B$672M – $2.4B$1.7B (0%)after a round410flatC0%
1 Feb 2024$1.7B$648M – $2.4B$1.7B (0%)after a round430flatC0%
1 Mar 2024$1.7B$836M – $2.4B$1.7B (0%)after a round440upB0%
1 Apr 2024$1.7B$827M – $2.4B$1.7B (0%)after a round440upB0%
1 May 2024$1.7B$818M – $2.4B$1.7B (0%)after a round440upB0%
1 Jun 2024$1.7B$808M – $2.4B$1.7B (0%)after a round440upB0%
1 Jul 2024$1.7B$727M – $2.4B$1.7B (0%)after a round440upB0%
1 Aug 2024$1.7B$727M – $2.5B$1.7B (0%)after a round480upC0%
1 Sep 2024$1.7B$714M – $2.5B$1.7B (-1%)after a round480upC0%
1 Oct 2024$1.7B$701M – $2.5B$1.7B (-1%)after a round480upC0%
1 Nov 2024$1.7B$688M – $2.5B$1.7B (-2%)after a round480upC0%
1 Dec 2024$1.7B$675M – $2.5B$1.7B (-2%)after a round480upC0%
1 Jan 2025$1.7B$662M – $2.5B$1.7B (-2%)after a round480upC0%
1 Feb 2025$1.7B$650M – $2.5B$1.7B (-3%)after a round480upC0%
1 Mar 2025$1.7B$639M – $2.5B$1.7B (-3%)after a round480upC0%
1 Apr 2025$1.7B$627M – $2.5B$1.7B (-3%)after a round480upC0%
1 May 2025$1.7B$615M – $2.5B$1.6B (-5%)after a round480upC0%
1 Jun 2025$1.7B$604M – $2.5B$1.6B (-6%)after a round480upC0%
1 Jul 2025$1.7B$474M – $2.5B$1.7B (-5%)after a round508upC0%
25 Jul 2025$1.7B$1.1B – $2.8B$1.8B (+10%)after a round508upB0%
1 Aug 2025$1.7B$1.1B – $2.8B$1.8B (+10%)after a round508upB0%
1 Sep 2025$1.7B$1.1B – $2.8B$1.8B (+9%)after a round508upB0%
1 Oct 2025$1.7B$1.1B – $2.8B$1.8B (+8%)after a round509flatB0%
1 Nov 2025$1.7B$1.1B – $2.8B$1.8B (+7%)after a round509flatB0%
1 Dec 2025$1.7B$1.1B – $2.8B$1.8B (+6%)after a round509flatB0%
1 Jan 2026$1.7B$1.1B – $2.8B$1.8B (+5%)after a round509flatB0%
1 Feb 2026$1.8B$1.1B – $2.8B$1.8B (+5%)after a round509flatB0%
1 Mar 2026$1.8B$1.1B – $2.8B$1.8B (+4%)after a round509flatB0%
1 Apr 2026$1.8B$1.1B – $2.8B$1.8B (+3%)after a round509flatB0%
30 Apr 2026$2.0B$1.4B – $3.8B$2.6B (+30%)after a round509flatB0%
1 May 2026$2.0B$1.4B – $3.8B$2.6B (+30%)after a round559upB0%
1 Jun 2026$2.1B$1.4B – $3.8B$2.7B (+28%)after a round584upB0%
1 Jul 2026$2.1B$1.4B – $3.8B$2.7B (+25%)after a round584upB0%
1 Aug 2026$2.2B$1.4B – $3.8B$2.7B (+22%)after a round584upB0%
1 Sep 2026$2.2B$1.4B – $3.8B$2.7B (+20%)after a round584upB0%
1 Oct 2026$2.3B$1.5B – $3.8B$2.7B (+18%)after a round621upB0%
24 Oct 2026$2.3B$1.5B – $3.8B$2.7B (+16%)after a round621upB0%

Key facts about Aidoc

Founded
2016
Headquarters
New York, United States
Employees
about 628 +22% in a year
Total raised
$510M
Funding rounds
6
Last round
Series E Apr 2026

Aidoc funding history

Aidoc has 6 funding rounds on record, from Apr 2017 to Apr 2026, $510M in total. None disclosed a valuation.

  1. Series E 29 Apr 2026

    Led by Goldman Sachs, Growth Equity at Goldman Sachs Alternatives; with General Catalyst, SoftBank Vision Fund, NVentures, Square Peg, SoftBank Investment Advisors.

    Sources: aidoc.com, aidoc.com, prnewswire.com and 3 more

    $150M

  2. Growth Equity 24 Jul 2025

    Led by General Catalyst, Square Peg; with NVentures, Hartford HealthCare, Mercy Corps Ventures, Sutter Health, WellSpan Health.

    Sources: finsmes.com, aidoc.com

    $150M

  3. Series D 16 Jun 2022

    Led by Technology Crossover Ventures, Alpha Intelligence Capital; with CDIB Capital.

    Sources: aidoc.com, mobihealthnews.com, calcalistech.com and 1 more

    $110M

  4. Series C 13 Jul 2021

    Led by General Catalyst.

    Sources: aidoc.com, en.globes.co.il, evtoday.com and 1 more

    $66M

  5. Series B 17 Apr 2019

    Led by Square Peg.

    Sources: aidoc.com, itnonline.com, prnewswire.com and 1 more

    $27M

  6. Other 26 Apr 2017no round page

    Led by TLV Partners; with Magma Ventures, Emerge.

    Sources: techcrunch.com, mobihealthnews.com, en.globes.co.il and 3 more

    $7.0M

Aidoc investors

17 investors have backed Aidoc; General Catalyst, Square Peg and Alpha Intelligence Capital and 4 more led at least one round.

What Aidoc does

Aidoc works in tech companies, with 15 recorded offerings and customers in healthcare.

Aidoc Medical Ltd. is an American company engaged in clinical artificial intelligence solutions for radiology, cardiology, neurovascular, and vascular imaging. The company develops AI-powered clinical platforms that integrate with existing IT infrastructure and support a range of imaging modalities, including CT, MRI, and ultrasound. Aidoc serves healthcare organizations worldwide, providing solutions designed to enhance patient care, operational efficiency, and clinical outcomes.

Description from Veridion's company data.

Products and services

  • Clinical AI Solutions Development
  • Radiology AI Solutions Development
  • Cardiology AI Solutions Development
  • Neurovascular AI Solutions Development
  • Vascular Imaging AI Solutions Development
  • AI-Powered Imaging Data Aggregation
  • AI-Driven Imaging Data Analysis
  • Clinical Imaging Platform Development
  • AI Platform Integration Services
  • Patient Imaging Data Processing
  • Clinical Imaging Workflow Optimization
  • Healthcare IT System Integration
  • Patient Outcome Enhancement Solutions
  • Clinical Efficiency Improvement Solutions
  • Medical Research Support Services

Markets

  • Healthcare

Technology

  • AI-Powered Clinical Solutions for Radiology
  • AI-Powered Clinical Solutions for Cardiology
  • AI-Powered Clinical Solutions for Neurovascular Imaging
  • AI-Powered Clinical Solutions for Vascular Imaging
  • AI-Powered Clinical Solutions for Imaging Data Aggregation and Analysis

Business model

  • Business-to-Business
  • Software-as-a-Service
  • Enterprise

Industry codes (NAICS)

  • 513210 Software Publishers 100% match

Questions about Aidoc

What is Aidoc worth?

Valuation $2.3B (range $1.5B to $3.8B), as of 24 Oct 2026.

Has Aidoc raised money?

Aidoc has 6 funding rounds on record, from Apr 2017 to Apr 2026, $510M in total. None disclosed a valuation.

Who has invested in Aidoc?

General Catalyst, Square Peg, Alpha Intelligence Capital, Goldman Sachs, Growth Equity at Goldman Sachs Alternatives and Technology Crossover Ventures, and 11 more. Lead investors include General Catalyst, Square Peg, Alpha Intelligence Capital and Goldman Sachs.

How many people work at Aidoc?

About 628, up 22% over the last year. Headcount grew from 120 in Jan 2021 to 621 in Sep 2026.

What does Aidoc do?

Aidoc works in tech companies, with 15 recorded offerings and customers in healthcare. Its main offerings are clinical AI solutions development, radiology AI solutions development and cardiology AI solutions development.

When was Aidoc founded, and where is it based?

Aidoc was founded in 2016 and is based in New York, United States. It has about 628 employees, up 22% over the last year.